![Joerg Gruber](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joerg Gruber
Fundador en Clubb Capital Ltd. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Rick Franklin | M | 78 |
Pathfinder LLC
Tarix Pharmaceuticals Ltd.
![]() Tarix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Tarix Pharmaceuticals Ltd. develops peptide drugs. The private company is based in Brookline, MA. The company was founded by Joerg Gruber, Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation.
SyntheMed, Inc.
![]() SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ
Tarix Orphan LLC
![]() Tarix Orphan LLC Pharmaceuticals: MajorHealth Technology Tarix Orphan LLC is a pharmaceutical company that manufactures pharmaceutical formulation products. The private company is based in Cambridge, MA. The company was founded by Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | 24 años |
Ilia Tikhomirov | M | - |
Bristol-Myers Squibb FCT bêta, Inc.
![]() Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada.
Formation Biologics Corp.
![]() Formation Biologics Corp. Miscellaneous Commercial ServicesCommercial Services Formation Biologics Corp. operates as a biopharmaceutical drug development company. It discovers and develops drugs and medicines for treatment of patients with cancers and orphan diseases. The company was founded in 2011 and is headquartered in Austin, TX. | 10 años |
Ekkehard Brysch | M | - |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | 17 años |
Wolfgang Brysch | M | - |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | 17 años |
Eva Brysch | F | - |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | - |
Gregg Beloff | M | 56 |
Bristol-Myers Squibb FCT bêta, Inc.
![]() Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada.
Formation Biologics Corp.
![]() Formation Biologics Corp. Miscellaneous Commercial ServicesCommercial Services Formation Biologics Corp. operates as a biopharmaceutical drug development company. It discovers and develops drugs and medicines for treatment of patients with cancers and orphan diseases. The company was founded in 2011 and is headquartered in Austin, TX. | 3 años |
Rudolf Stäger | M | 67 |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | 17 años |
Walter Blättler | M | 75 |
Bristol-Myers Squibb FCT bêta, Inc.
![]() Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada.
Formation Biologics Corp.
![]() Formation Biologics Corp. Miscellaneous Commercial ServicesCommercial Services Formation Biologics Corp. operates as a biopharmaceutical drug development company. It discovers and develops drugs and medicines for treatment of patients with cancers and orphan diseases. The company was founded in 2011 and is headquartered in Austin, TX. | 7 años |
Thomas Hughes | M | 64 |
Constant Therapeutics LLC
| 1 años |
Werner Wolf | M | - |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | 13 años |
Niclas Stiernholm | M | - |
Tarix Pharmaceuticals Ltd.
![]() Tarix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Tarix Pharmaceuticals Ltd. develops peptide drugs. The private company is based in Brookline, MA. The company was founded by Joerg Gruber, Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | - |
Thomas Christély | M | - |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | 3 años |
Alex Shlyankevich | M | 63 |
Constant Therapeutics LLC
| - |
Markus W. Wenner | M | 56 |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | 5 años |
Ralf Haubert | M | - |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | - |
Annerose Kuhnke | F | - |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | - |
Sara Schumann | F | - |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | 7 años |
Beate Ludescher | F | - |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | - |
Bettina Richard | F | - |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | - |
Christoph von Moos | M | - |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | - |
Lia Petridou | F | - |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Peter Cohen | M | 77 |
Shearson Lehman Bros., Inc.
![]() Shearson Lehman Bros., Inc. Investment Banks/BrokersFinance Part of Lehman Brothers Holdings, Inc., Shearson Lehman Bros., Inc. provides security broker services. The company is based in New York, NY. | 19 años |
John Benson | M | 62 |
Pathfinder LLC
SyntheMed, Inc.
![]() SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 5 años |
Robert P. Hickey | M | 78 |
SyntheMed, Inc.
![]() SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 15 años |
Peter Donald Walker | M | 72 |
Scandinavian Minerals Ltd.
![]() Scandinavian Minerals Ltd. Other Metals/MineralsNon-Energy Minerals Scandinavian Minerals Ltd. explores for copper and nickel. The company is based in Toronto, Canada and has subsidiaries in Finland and Sweden. Scandinavian Minerals was acquired by First Quantum Minerals Ltd. on June 18, 2008 for $258.21 million. The Canadian company was founded in 2003 by Peter Donald Walker. | 12 años |
Christian de Saint-Rome | M | - |
Scandinavian Minerals Ltd.
![]() Scandinavian Minerals Ltd. Other Metals/MineralsNon-Energy Minerals Scandinavian Minerals Ltd. explores for copper and nickel. The company is based in Toronto, Canada and has subsidiaries in Finland and Sweden. Scandinavian Minerals was acquired by First Quantum Minerals Ltd. on June 18, 2008 for $258.21 million. The Canadian company was founded in 2003 by Peter Donald Walker. | - |
Tuomo Vesa Mäkelä | M | 74 |
Scandinavian Minerals Ltd.
![]() Scandinavian Minerals Ltd. Other Metals/MineralsNon-Energy Minerals Scandinavian Minerals Ltd. explores for copper and nickel. The company is based in Toronto, Canada and has subsidiaries in Finland and Sweden. Scandinavian Minerals was acquired by First Quantum Minerals Ltd. on June 18, 2008 for $258.21 million. The Canadian company was founded in 2003 by Peter Donald Walker. | - |
Corinne Mundin | F | - |
SyntheMed, Inc.
![]() SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 3 años |
Albert McLelland | M | 66 |
Shearson Lehman Bros., Inc.
![]() Shearson Lehman Bros., Inc. Investment Banks/BrokersFinance Part of Lehman Brothers Holdings, Inc., Shearson Lehman Bros., Inc. provides security broker services. The company is based in New York, NY. | 3 años |
Chris L. Pia | M | - |
Shearson Lehman Bros., Inc.
![]() Shearson Lehman Bros., Inc. Investment Banks/BrokersFinance Part of Lehman Brothers Holdings, Inc., Shearson Lehman Bros., Inc. provides security broker services. The company is based in New York, NY. | - |
John S. Hoffer | M | - |
SyntheMed, Inc.
![]() SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 6 años |
John Kearney | M | 74 |
Scandinavian Minerals Ltd.
![]() Scandinavian Minerals Ltd. Other Metals/MineralsNon-Energy Minerals Scandinavian Minerals Ltd. explores for copper and nickel. The company is based in Toronto, Canada and has subsidiaries in Finland and Sweden. Scandinavian Minerals was acquired by First Quantum Minerals Ltd. on June 18, 2008 for $258.21 million. The Canadian company was founded in 2003 by Peter Donald Walker. | 5 años |
David G. Motherwell | M | - |
Shearson Lehman Bros., Inc.
![]() Shearson Lehman Bros., Inc. Investment Banks/BrokersFinance Part of Lehman Brothers Holdings, Inc., Shearson Lehman Bros., Inc. provides security broker services. The company is based in New York, NY. | 1 años |
Zen Chu | M | 52 |
Pathfinder LLC
| - |
Mitch Pletcher | M | - |
Shearson Lehman Bros., Inc.
![]() Shearson Lehman Bros., Inc. Investment Banks/BrokersFinance Part of Lehman Brothers Holdings, Inc., Shearson Lehman Bros., Inc. provides security broker services. The company is based in New York, NY. | 1 años |
Brett D. McKamey | M | - |
Shearson Lehman Bros., Inc.
![]() Shearson Lehman Bros., Inc. Investment Banks/BrokersFinance Part of Lehman Brothers Holdings, Inc., Shearson Lehman Bros., Inc. provides security broker services. The company is based in New York, NY. | - |
Anthony William Tolcher | M | - |
Bristol-Myers Squibb FCT bêta, Inc.
![]() Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | - |
Sven Zimmermann | M | 53 |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | - |
John Brooks | M | 73 |
Pathfinder LLC
| - |
Brock Reeve | M | 67 |
Pathfinder LLC
| - |
Bryan Macintosh Benitz | M | 90 |
Scandinavian Minerals Ltd.
![]() Scandinavian Minerals Ltd. Other Metals/MineralsNon-Energy Minerals Scandinavian Minerals Ltd. explores for copper and nickel. The company is based in Toronto, Canada and has subsidiaries in Finland and Sweden. Scandinavian Minerals was acquired by First Quantum Minerals Ltd. on June 18, 2008 for $258.21 million. The Canadian company was founded in 2003 by Peter Donald Walker. | 9 años |
Josh Goldberg | M | - |
Shearson Lehman Bros., Inc.
![]() Shearson Lehman Bros., Inc. Investment Banks/BrokersFinance Part of Lehman Brothers Holdings, Inc., Shearson Lehman Bros., Inc. provides security broker services. The company is based in New York, NY. | 3 años |
Walter R. Maupay | M | 84 |
SyntheMed, Inc.
![]() SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 15 años |
David Allan | M | 82 |
SyntheMed, Inc.
![]() SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 8 años |
D. Deacon | M | 75 |
Scandinavian Minerals Ltd.
![]() Scandinavian Minerals Ltd. Other Metals/MineralsNon-Energy Minerals Scandinavian Minerals Ltd. explores for copper and nickel. The company is based in Toronto, Canada and has subsidiaries in Finland and Sweden. Scandinavian Minerals was acquired by First Quantum Minerals Ltd. on June 18, 2008 for $258.21 million. The Canadian company was founded in 2003 by Peter Donald Walker. | - |
Frank Ramsperger | M | - |
Scandinavian Minerals Ltd.
![]() Scandinavian Minerals Ltd. Other Metals/MineralsNon-Energy Minerals Scandinavian Minerals Ltd. explores for copper and nickel. The company is based in Toronto, Canada and has subsidiaries in Finland and Sweden. Scandinavian Minerals was acquired by First Quantum Minerals Ltd. on June 18, 2008 for $258.21 million. The Canadian company was founded in 2003 by Peter Donald Walker. | - |
John Alam | M | 62 |
Pathfinder LLC
| - |
Andy Morse | M | 78 |
Shearson Lehman Bros., Inc.
![]() Shearson Lehman Bros., Inc. Investment Banks/BrokersFinance Part of Lehman Brothers Holdings, Inc., Shearson Lehman Bros., Inc. provides security broker services. The company is based in New York, NY. | - |
Robert J. Cresci | M | 80 |
Shearson Lehman Bros., Inc.
![]() Shearson Lehman Bros., Inc. Investment Banks/BrokersFinance Part of Lehman Brothers Holdings, Inc., Shearson Lehman Bros., Inc. provides security broker services. The company is based in New York, NY. | - |
Gary S. Bresky | M | 57 |
Shearson Lehman Bros., Inc.
![]() Shearson Lehman Bros., Inc. Investment Banks/BrokersFinance Part of Lehman Brothers Holdings, Inc., Shearson Lehman Bros., Inc. provides security broker services. The company is based in New York, NY. | 1 años |
Eli Pines | M | 78 |
SyntheMed, Inc.
![]() SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 8 años |
Marc R. Sportsman | M | 69 |
SyntheMed, Inc.
![]() SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 2 años |
Barry Frankel | M | 73 |
SyntheMed, Inc.
![]() SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 8 años |
Jan Weber | M | - |
Metriopharm AG
![]() Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | - |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 30 | 55.56% |
Suiza | 16 | 29.63% |
Canadá | 11 | 20.37% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Joerg Gruber
- Red Personal